ProPhase Labs (NASDAQ:PRPH – Get Free Report) will likely be posting its Q3 2026 results on Monday, November 16th. Analysts expect ProPhase Labs to announce earnings of $2.05 per share and revenue of $11.98 million for the quarter. Investors can find conference call details on the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Wednesday, November 18, 2026 at 2:00 PM ET.
ProPhase Labs Trading Up 6.5%
Shares of PRPH stock opened at $0.00 on Friday. ProPhase Labs has a 12 month low of $0.00 and a 12 month high of $3.00. The company has a market cap of $142,536.10, a PE ratio of -0.00 and a beta of 0.07. The company has a quick ratio of 0.14, a current ratio of 0.14 and a debt-to-equity ratio of 0.14. The business’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.08.
About ProPhase Labs
ProPhase Labs, Inc. is a diversified healthcare company focused on diagnostics, genomics, and related healthcare services. Through its operating businesses, the company develops and provides clinical laboratory testing, genetic testing, and data-driven health solutions for consumers, healthcare providers, researchers, and pharmaceutical companies. ProPhase Labs’ activities have included molecular and genomic testing, clinical research support, and precision-health services. Its portfolio has also included Nebula Genomics, a genomics platform designed to provide whole-genome sequencing and enable individuals to manage and share their genetic data.
Read More
- Five stocks we like better than ProPhase Labs
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for ProPhase Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProPhase Labs and related companies with MarketBeat.com's FREE daily email newsletter.
